Stopping and Restarting Semaglutide: What Actually Happens

What happens to your weight when you stop semaglutide?

This is the question most people are really asking, and the honest answer is that stopping semaglutide reverses much of its effect. The medicine works by activating GLP-1 receptors involved in appetite regulation and the feeling of fullness. When you stop taking it, those effects fade. Appetite returns to its previous level, food feels less satisfying sooner into a meal, and the biological conditions that made weight loss difficult in the first place reassert themselves.

The STEP 4 withdrawal trial, published in the New England Journal of Medicine, followed participants who had lost weight on semaglutide and then switched to placebo. Within 52 weeks of stopping, the average participant had regained about two-thirds of the weight they had lost. Cardiometabolic markers (blood pressure, blood sugar, waist circumference) moved back towards pre-treatment levels at a similar rate.

That is not a failure of the medicine. It reflects the nature of obesity as a chronic condition rather than one that is resolved after a course of treatment. Many people find this difficult to hear, particularly if they stopped because of cost or side effects rather than by choice. You are not alone in that position, and it does not mean treatment cannot work for you again. The NHS patient information on semaglutide sets out these effects clearly.

Can you restart semaglutide after stopping, and does the dose matter?

Yes, most people can restart. The clinical and practical question is where you restart on the dose ladder. Semaglutide is titrated gradually for a reason: the escalation from a lower starting dose up through the schedule exists to allow your body to adjust and to limit gastrointestinal side effects. Jump back in at a higher dose after a long break and those side effects (nausea, vomiting, disrupted digestion) are likely to return with similar force to when you first started.

The general principle followed by prescribers is that the longer the gap, the further back down the dose schedule you may need to restart. A pause of a few weeks might allow a return close to your previous dose. A break of several months usually means stepping back to a lower dose and re-titrating up. There is no universal rule, because individual tolerance varies. Your prescriber will look at your treatment history and work out the safest restart point with you.

Our guidance on restarting semaglutide after a break goes into the specific dose considerations in more detail. If your gap has been around a month specifically, the page on restarting after a month addresses that window directly.

Why did you stop, and does it change the approach to restarting?

The reason for stopping matters more than people expect. If you stopped because of side effects (persistent nausea, gastrointestinal discomfort, fatigue) restarting at a lower dose with a slower titration rate can make a real difference. Some people who could not tolerate 1.0mg find 0.5mg manageable for longer before moving up, and that slower pace is entirely legitimate clinically.

If you stopped because of cost, it is worth understanding what a full private prescription includes before assuming a cheaper option elsewhere is equivalent. The price of treatment through a regulated UK pharmacy covers more than the medicine itself. The Wegovy cost page explains what private pricing typically includes. Separately, if you stopped because the medicine became unavailable during supply shortages, that is a different scenario again: supply of Wegovy has improved, and a prescriber can confirm current availability at consultation.

If you stopped because you felt you had reached your goal and treatment was no longer needed, it is worth knowing that the NICE guidance for semaglutide (set out in NICE technology appraisal TA875) specifies a maximum of two years within specialist services for NHS-funded treatment. Private treatment does not carry the same hard time limit, but the clinical picture should still be reviewed regularly. Your prescriber should know whether continuing, pausing or stopping permanently is the right call.

What is the right process for stopping and restarting Wegovy safely?

The Patient Information Leaflet for Wegovy covers missed doses and what to do if treatment is interrupted, and the practical answer for a single missed dose is different from the answer for a deliberate multi-week pause. For anything more than a brief accidental gap, the right step is to contact your prescriber rather than manage the dose decision yourself.

On the stopping side, there is no clinical requirement to taper semaglutide gradually the way some other medicines are tapered. You can stop without a slow dose reduction. What you should not do is stop abruptly and then restart at a high dose several months later without clinical input. The detailed practical guidance on stopping Wegovy covers what to expect in the days and weeks after your last dose.

For restarting, the process through a regulated pharmacy involves a fresh clinical assessment. A real prescriber reviews your history, confirms suitability, and determines the appropriate starting point. Our prescribers do this the same day for consultations submitted before noon, Monday to Friday. If you want to understand the broader picture of how semaglutide works before committing to restarting, the semaglutide overview and the Wegovy treatment page are good places to start. You can also read about weight management treatment options more broadly if you are unsure whether Wegovy is still the right fit for you. When you are ready, start a free consultation and our clinical team will take it from there.